Top

Journal of Bone and Mineral Metabolism

Published in:

01-03-2019 | Letter to the Editor

Comment on: “Effects of interventions with a physical activity component on bone health in obese children and adolescents: a systematic review and meta-analysis”

Authors: Mohammad Alwardat, Nuha Alwardat

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2019

Excerpt

Dear Editor, …

Chaplais E, Naughton G, Greene D, Dutheil F, Pereira B, Thivel D, Courteix D (2018) Effects of interventions with a physical activity component on bone health in obese children and adolescents: a systematic review and meta-analysis. J Bone Miner Metab 36:12–30CrossRefPubMed

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100CrossRefPubMedPubMedCentral

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 19:2008–2012CrossRef

Title: Comment on: “Effects of interventions with a physical activity component on bone health in obese children and adolescents: a systematic review and meta-analysis”
Authors: Mohammad Alwardat
Nuha Alwardat
Publication date: 01-03-2019
Publisher: Springer Japan
Published in: Journal of Bone and Mineral Metabolism / Issue 2/2019
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-018-0921-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Potential association with early changes in serum calcium level after starting or switching to denosumab combined with eldecalcitol

The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese male patients with osteoporosis

Sclerostin and parathyroid hormone responses to acute whole-body vibration and resistance exercise in young women

Optimal administration frequency and dose of teriparatide for acceleration of biomechanical healing of long-bone fracture in a mouse model

Serum homocysteine levels are affected by renal function during a 3-year period of minodronate therapy in female osteoporotic patients

Accumulation of microdamage at complete and incomplete fracture sites in a patient with bilateral atypical femoral fractures on glucocorticoid and bisphosphonate therapy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials